Description of theme 1
Description of theme 2
Description of theme 3
   
 

Department of Medical Microbiology
PO Box 9101
6500 HB Nijmegen
The Netherlands
T: +31 24 3617600
F: +31 24 3540339

Paul Verweij is the chairman of the Department of Medical Microbiology since January 2002. In addition, he is member of the board of the Nijmegen Center for Infection, Inflammation and Immunity (N4i). He is also a full professor of Medical Microbiology.
Prof Dr. Paul E. Verweij

The main research interest is the management of invasive fungal diseases. Topics of interest include the diagnosis of invasive mycoses by non-cultured based methods such as biological markers and fungal DNA. The emergence of azole resistance in Aspergillus is another topic of interest which addresses the origin and epidemiology of resistance, and clinical management. Third topic is efficacy of antifungal agents in relation to pharmacodynamic and pharmacokinetic parameters using experimental models of fungal infection.
 
Recent key publications

Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. PLoS Med. 2008 Nov 11;5(11):e219.

Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ. Clin Infect Dis. 2008 Nov 15;47(10):1270-6.

Multiple-triazole-resistant aspergillosis. Verweij PE, Mellado E, Melchers WJ.N Engl J Med. 2007 Apr 356(14):1481-3.